Prestige Consumer Opens Its FY2023 With Revenue Thirst Quenched By Hydralyte International Sales
Executive Summary
Hydralyte line has 90% share in Australia’s hydration market and accounted for a large share of firm’s overall sales growth in its latest quarter as 28.9% international sales growth to $34.5m offset flat North American results at $242.4m.
You may also be interested in...
Prestige Consumer Focused On ‘Smaller Categories’ As Larger Firms Change Industry Landscape
Larger consumer health firms are “looking to move-the-needle opportunities, which are big brands, big categories, different regions than we compete in as part of their business objective,” says CEO Ron Lombardi as PCH reports revenues down slightly from year-ago period at $286.3m.
Prestige Consumer’s International Cough/Cold Sales Offset FX Loss In Latest Results
Higher cough/cold OTC sales along with Hydralyte line and sore throat treatments bright spots in October-December offset by COVID-19 and continuing supply chain constraints.
Prestige Consumer Targets Improving Delivering On Demand, Considers Price Hikes As Costs Grow
Around half its reported 4.7% growth to $289.3 million in latest came from price increases. Impact on supply chain continues from problems caused by novel coronavirus pandemic.